Notable Analyst Rating Changes 11/20: DSX, BIDU, ATR Upgraded; EGLE, SOL, AMED, PAY Downgraded
More News related to AMED
- Amedisys to Present at the Jefferies 3rd Annual Healthcare Conference
- Amedisys to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
- Amedisys (AMED) Tops Q1 EPS by 2c; Guides
- Amedisys (AMED) Reports Mixed Q1 Earnings; Guides FY09
- Trading Radar for 4/28: Bristol-Myers Squibb (BMY), Pfizer (PFE), BP (BP), Sun Micro (JAVA), Deutsche Bank (DB), E*TRADE (ETFC), Level 3 (LVLT) Report; Consumer Confidence Due
More News related to ATR
- AptarGroup, Inc. Announces Second Quarter Conference Call Information
- Baird Initiates Coverage on AptarGroup (ATR) with a Neutral
- Morning Movers 4/16: CSKI, GMKT, UIS, JAH, PLXS, FCS, NOK Higher; GGP, NOBL, DSCO, BGG, CIM, IIIN Lower
- After-Hours Movers 4/15: PLCM, ATR, DRE, UFPI, KMP Lower
- AptarGroup (ATR) Reports In-Line Q1 EPS of $0.38; Guides Q2 Below the Street
More News related to BIDU
- Deutsche Bank Boosts Price Target On Baidu.com (BIDU) to $374
- Susquehanna Boosts Price Target on Baidu.com (BIDU) to $350
- Notable Analyst Rating Changes 6/19: CCL, ARM, SPWRA, FRO Upgraded; VMW, LDK, RFMD Downgraded
- HSBC Starts Bearish Coverage on Baidu.com (BIDU)
- Goldman Sachs Boosted Its Price Target on Baidu (BIDU) to $350
UPGRADES:
J.P. Morgan upgrades Diana Shipping (NYSE: DSX) from Neutral to Outperform.
Credit Suisse upgrades Baidu.com (Nasdaq: BIDU) from Underperform to Neutral with a $138 price target.
Merrill Lynch upgrades AptarGroup (NYSE: ATR) from Neutral to Buy.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
J.P. Morgan downgrades Eagle Bulk Shipping (Nasdaq: EGLE) from Overweight to Underweight.
Deutsche Bank downgrades ReneSola (NYSE: SOL) from Buy to Hold.
Deutsche Bank downgrades Amedisys Inc (Nasdaq: AMED) from Buy to Hold. Price target lowered from $75 to $53.
J.P. Morgan downgrades VeriFone (NYSE: PAY) from Overweight to Neutral.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
UBS initiates coverage on Boston Scientific (NYSE: BSX) with a Buy rating.
Goldman Sachs initiates coverage on Exlservice Holdings, Inc. (Nasdaq: EXLS) with a Neutral rating.
Cantor Fitzgerald initiates coverage on Inland Real Estate (NYSE: IRC) with a Buy. Price target $14.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
-2.28
+19.79Related Entities
- Credit Suisse
- Deutsche Bank
- UBS
- Cantor Fitzgerald
- JPMorgan
- Goldman Sachs
- Merrill Lynch
- Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
